A Sudy to Evaluate the Efficacy and Safety of TNM001 in High-risk Infants

Clinical trial NCT06710925 · COMPLETED

Trial details

NCT number: NCT06710925
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2024-11-28
Primary completion: 2025-07-27
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.